Chinese lilac

Syringa, primarily comprising species such as Syringa vulgaris and S. pinnatifolia, originates from various regions including Europe and Asia. Traditionally, there are no documented uses of Syringa in any specific medical traditions. Scientific evidence suggests that extracts from S. vulgaris flowers exhibit significant protective effects against oxidative stress by reducing lipid peroxidation and protein carbonylation without affecting blood clotting times. Additionally, studies indicate that flower-derived biovolatile organic compounds (BVOCs) from S. oblata can impact mice's behavior and hematological parameters, while a lignan-rich fraction A from S. pinnatifolia shows analgesic effects through inhibition of NF-κB and MAPK pathways. Climate change models predict earlier spring phenophases for common lilac across Slovenia by the end of the 21st century. To date, no major safety concerns or recorded drug interactions have been identified with Syringa species.

仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。